Hong Kong, China

Wei Chen

This inventor holds 1 USPTO granted patent. Top assignee: City University of Hong Kong. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Chen. Retrieved from https://idiyas.com/inventor/wei-chen-2f802a9s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wei Chen in Transdermal Delivery Devices

Introduction

Wei Chen is an accomplished inventor based in Hong Kong, CN. He has made significant contributions to the field of transdermal delivery systems. His innovative work focuses on developing composites that enhance the effectiveness of drug delivery through the skin.

Latest Patents

Wei Chen holds a patent for a composite designed for preparing a transdermal delivery device. The patent, titled "Composite for preparing a transdermal delivery device and method for synthesizing the composite thereof," involves a composite that includes at least one polymer and at least one macrocyclic molecule. This unique combination is engineered to form a complex that improves the delivery of therapeutic agents through the skin.

Career Highlights

Wei Chen is affiliated with the City University of Hong Kong, where he contributes to research and development in innovative drug delivery systems. His work is recognized for its potential to improve patient outcomes through more effective medication administration.

Collaborations

Wei Chen collaborates with Xianfeng Chen, enhancing the research efforts in their field. Their partnership aims to push the boundaries of current technologies in transdermal delivery.

Conclusion

Wei Chen's contributions to the field of transdermal delivery devices exemplify the importance of innovation in healthcare. His patent and ongoing research at the City University of Hong Kong highlight the potential for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…